Roche under fire again: Mylan launches Herceptin copycat in latest blow to blockbuster trio

2nd December 2019 Uncategorised 0

Much has been made of the challenges Roche’s blockbuster oncology troika faces with U.S. biosimilars hitting the market in quick succession. So far, those challengers haven’t made much of a dent in Roche’s sales stateside—but a new challenger could help tip the scales. 

More: Roche under fire again: Mylan launches Herceptin copycat in latest blow to blockbuster trio
Source: fierce